Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
It was never the combo
Causal effects of genetically determined metabolites on cancers included lung, breast, ovarian cancer, and glioma: a Mendelian randomization study
Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes CONCENTRATION CONCENTRATION CONCENTRATION CONCENTRATION CONCENTRATION Tirzepatide Tirzepatide Tirzepatide Tirzepatide Tirzepatide 60mg/3mL 60mg/3mL 60mg/3mL 60mg/3mL PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM Injectable solution Injectable solution Injectable solution Injectable solution Injectable solution 1 vial 60 mg of Tirzepatide (Lyophilized Powder) 1 vial 3 ml of bacteriostatic water 1 vial 60 mg of Tirzepatide (Lyophilized Powder) 1 vial 3 ml of bacteriostatic water Efficacy Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, designed to enhance glycemic control in patients with type 2 diabetes
No, in Canada, Tirzepatide is not available over-the-counter
US$ 29.93
US$ 26.65
US$ 27.58
US$ 25.59
US$ 20.94
US$ 22.62
